Compounded Semaglutide: What You Need to Know in 2026

What Is Compounded Semaglutide?

Compounded semaglutide is the same active molecule as Ozempic/Wegovy, but prepared by compounding pharmacies rather than manufactured by Novo Nordisk. It became widely available during the brand-name shortage and remains popular due to significantly lower cost.

Cost Comparison

• Brand Wegovy: $1,349/month list price ($349+ self-pay)
• Compounded semaglutide: $150-350/month from telehealth providers
• Generic liraglutide: $150-350/month (different drug, less effective)

Is It Safe?

Compounded semaglutide from a licensed 503B pharmacy is generally considered safe. However, quality varies significantly between providers.

Green flags:

• Uses a licensed 503B outsourcing facility
• Provides Certificate of Analysis (COA) for each batch
• Third-party purity testing
• Prescribed by a licensed physician after medical evaluation
• Clear dosing instructions

Red flags:

• No COA available
• Unusually cheap ($50-100/month)
• No medical evaluation required
• Ships from overseas
• "Research use only" labeling

How It Differs from Brand

• Same active ingredient (semaglutide)
• May use different salt forms (semaglutide sodium vs acetate)
• Different inactive ingredients/preservatives
• Not FDA-approved as a finished product (the ingredient is FDA-approved)
• No long-term stability data like brand-name

The Legal Landscape in 2026

The FDA has been tightening regulations on compounded GLP-1s. As brand-name supply stabilizes, the legal window for compounding may narrow. Stay informed about regulatory changes that could affect availability.

Bottom Line

Compounded semaglutide from a reputable source is a legitimate option for people who can't afford or access brand-name medications. Do your due diligence on the pharmacy and provider.